MB
Mani Bhushan
About Mani Bhushan
Data last updated:
Mani Bhushan is a Director at Rapizenix Healthcare Private Limited (since 2023) and Director at Medzone Science Private Limited (since 2021). The companies operate in Infrastructure and Utilities and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹16.41 Cr; the largest is Rapizenix Healthcare Private Limited at ₹10.03 Cr (FY 2025). Earlier, Mani Bhushan was a Director at Elysia Medical Product Private Limited (2017–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Dec 2023 | 2023 | ₹10.03 Cr (FY 2025) | Active | |
| Director | 13 Nov 2021 | 2020 | ₹6.38 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Dec 2017 | 2017 | ₹10.34 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mani Bhushan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Kumar Prasad | 06806321 | Rapizenix Healthcare Private Limited | Director |
| Rishu Rani | 09397098 | Medzone Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mani Bhushan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mani Bhushan
Mani Bhushan currently holds 2 directorships: Rapizenix Healthcare Private Limited (Director, since 14 Dec 2023, revenue ₹10.03 Cr (FY 2025)); Medzone Science Private Limited (Director, since 13 Nov 2021, revenue ₹6.38 Cr (FY 2024)).
Mani Bhushan was first appointed on 11 Dec 2017 as Director at Elysia Medical Product Private Limited. The most recent appointment on record is 14 Dec 2023 at Rapizenix Healthcare Private Limited.
The 2 current companies of Mani Bhushan that report revenue have a combined latest revenue of ₹16.41 Cr: Rapizenix Healthcare Private Limited ₹10.03 Cr (FY 2025); Medzone Science Private Limited ₹6.38 Cr (FY 2024).
Mani Bhushan held 1 earlier board appointment: Elysia Medical Product Private Limited (Director, 11 Dec 2017 to 15 Feb 2023).
The current boards of Mani Bhushan's companies include Manish Kumar Prasad (Rapizenix Healthcare Private Limited), Rishu Rani (Medzone Science Private Limited).